Artio Medical has acquired Flow Forward Medical, a medical device company developing methods for establishing and maintaining vascular access sites.

This stock-for-stock merger transaction in which Flow Forward merged with and into Artio was approved by the Board of Directors and stockholders of both companies. The transaction closed on 8 June 2020.

“Flow Forward’s venous dilation technology is highly complementary to Artio’s existing peripheral vascular portfolio, with significant overlap in physician call points and procedures,” commented F Nicholas Franano, president and CEO of Artio Medical. “This acquisition provides a unique opportunity to diversify Artio’s endovascular pipeline, which will now include next generation vascular access solutions for kidney failure patients.”

Related: Cerus Endovascular receives CE Mark for aneurysms treatment device